Intermittent low-dose finasteride is as effective as daily administration for the treatment of hirsute women

Fertility and Sterility

Volumn 82, Issue 3, 2004, Pages 752-755

  Tartagni, Massimo ^a,d   Schonauer, Matteo Maria ^b   Cicinelli, Ettore ^b   Petruzzelli, Filomena ^b   De Pergola, Giovanni ^c   De Salvia, Maria Antonietta ^d   Loverro, Giuseppe ^a  

^a Clinica Ostetrica e Ginecologica III   (Italy)

^b Clinica Ostetrica e Ginecologica I   (Italy)

^c DETO   (Italy)

^d UNIVERSITY OF BARI   (Italy)

Author keywords

Finasteride; hirsutism; idiopathic hirsutism; low dose; polycystic ovary syndrome

Indexed keywords

FINASTERIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HIRSUTISM; HUMAN; LABORATORY TEST; LIBIDO DISORDER; LOW DRUG DOSE; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; FEMALE; FINASTERIDE; HIRSUTISM; HUMANS; REPRODUCIBILITY OF RESULTS;

EID: 4544261156     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2004.02.118     Document Type: Article

References (18)

1. D. Ferriman, J.D. Gallwey Clinical assessment of body hair growth in women J Clin Endocrinol Metab 21 1961 1440 1447
2. R. Erkkola, K. Ruutiainen Hirsutism definitions and etiology Ann Med 22 1990 99 9103
3. R. Azziz The evaluation and management of hirsutism Obstet Gynecol 101 2003 995 991007
4. R.A. Lobo, U. Goebelsmann, R. Horton Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome J Clin Endocrinol Metab 57 1983 393 397
5. R. Kuttenn, I. Mowszowicz, G. Schaison, P. Mauvais-Jarvis Androgen production and skin metabolism in hirsutism J Endocrinol 75 1977 83 91
6. P. Serafini, F. Ablan, R.A. Lobo 5α-Reductase activity in the genital skin of hirsute women J Clin Endocrinol Metab 60 1985 349 355
7. R.J. Paulson, P.C. Serafini, J.A. Catalino, R.A. Lobo Measurements 3α, 17β-drostanediol glucuronide in serum and urine and the correlation with skin 5α-reductase activity Fertil Steril 46 1986 222 226
8. R. Azziz, E. Carmina, M.E. Sawaya Idiophatic hirsutism Endocr Rev 21 2000 347 362
9. R.S. Rittmaster Finasteride N Engl J Med 330 1994 120 125
10. R. Castello, F. Tosi, F. Perrone, C. Negri, M. Muggeo, P. Moghetti Outcome of long term treatment with the 5α-reductase inhibitor finasteride in the idiopathic hirsutism. Clinical and hormonal effects during a 1-year course of therapy and 1-year follw up Fertil Steril 66 1996 734 740
11. E.M. Lakryc, E.L. Motta, J.M. Soares Jr, M.A. Haidar, G.R. de Lima, E.C. Baracat The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism Gynecol Endocrinol 17 2003 57 63
12. S. Venturoli, O. Marescalchi, F.M. Colombo, S. Macrelli, B. Ravaioli, A Bagnoli A prospective randomized trial comparing low-dose flutamide, finasteride, ketoconozole and cyproterone acetate-estrogen regimens in the treatment of hirsutism J Clin Endocrinol Metab 84 1999 1304 1310
13. F. Bayram, I.I. Muderris, M. Guven, F. Kelestimur Comparison of high-dose finasteride (5 mg/day) versus low-dose finasteride (2.5 mg/day) in the treatment of hirsutism Eur J Endocrinol 147 2002 467 471
14. M. Tartagni, L.M. Schonauer, M.A. De Salvia, E. Cicinelli, G. De Pergola, V. D'Addario Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism Fertil Steril 73 2000 718 723
15. Expert Committee Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diab Care 20 1997 1183 1197
16. E. Faloia, S. Filipponi, V. Mancini, S. Di Marco, F. Mantero Effect of finasteride in idiopathic hirsutism J Endocrinol Invest 21 1998 694 698
17. J.F. Steiner Clinical pharmacokinetics and pharmacodynamics of finasteride Clin Pharmacokinet 30 1996 16 27
18. Gormley GJ, Stoner E, Rittmaster RS, Gregg H, Thompson DL, Lasseter KC, et al. Effects of finasteride (MK-906), a 5 α-reductase inhibitor, on circulating androgens in male volunteers. J Clin Endocrinol Metab 1990;70(4):1136-41.